There are 298 resources available
17P - Gynaecologic carcinosarcomas (GCS)’s chemotherapy landscape: A retrospective analysis from Hospital Clinico San Carlos (HCSC), academic, referral centre for rare gynaecological malignancies in Madrid (Spain)
Presenter: Beatriz Diez
Session: Poster Display session
Resources:
Abstract
18P - Decoding the interplay of deubiquitinating enzymes (DUBs) in metastasis and chemoresistance of gynaecological cancers
Presenter: Ravi Chauhan
Session: Poster Display session
Resources:
Abstract
19P - Long-term fatigue after treatments for non-epithelial ovarian cancer survivors
Presenter: Florence Joly Lobbedez
Session: Poster Display session
Resources:
Abstract
20P - Outcome of neuroendocrine carcinoma of the cervix: A decade of experience at the National Cancer Institute, Malaysia
Presenter: Rizma Mohd Zaid
Session: Poster Display session
Resources:
Abstract
21P - Age-adjusted trends in patients with head and neck sarcomas
Presenter: Amr Aly
Session: Poster Display session
Resources:
Abstract
23P - Preclinical evaluation of targeted agents alone or combined with chemotherapy in the adenoid cystic carcinoma cells
Presenter: Andrea Abate
Session: Poster Display session
Resources:
Abstract
24P - Sinonasal neuroendocrine tumors: Analysis of therapeutic strategies in an ultra-rare tumor
Presenter: Javier Martinez Trufero
Session: Poster Display session
Resources:
Abstract
25P - Risk of second primary head and neck cancer in patients with head and neck soft tissue sarcoma
Presenter: Amr Aly
Session: Poster Display session
Resources:
Abstract
28P - Decoding biomarkers of immune activation in neuroendocrine carcinomas treated with ipilimumab and nivolumab using a multiomic approach
Presenter: Cara Haymaker
Session: Poster Display session
Resources:
Abstract
29P - First-line of camrelizumab, apatinib mesylate and chemotherapy for advanced high-grade neuroendocrine tumors (NETS): A single center, single arm, exploratory study
Presenter: Jing Xu
Session: Poster Display session
Resources:
Abstract